GHELARDONI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 11.601
AS - Asia 4.508
EU - Europa 3.985
SA - Sud America 530
Continente sconosciuto - Info sul continente non disponibili 187
AF - Africa 169
OC - Oceania 17
Totale 20.997
Nazione #
US - Stati Uniti d'America 11.149
IT - Italia 1.485
SG - Singapore 1.379
CN - Cina 1.356
HK - Hong Kong 663
SE - Svezia 624
BR - Brasile 435
DE - Germania 388
VN - Vietnam 346
CA - Canada 338
BG - Bulgaria 282
GB - Regno Unito 221
TR - Turchia 208
UA - Ucraina 166
FR - Francia 162
FI - Finlandia 141
RU - Federazione Russa 129
JP - Giappone 116
IN - India 101
AT - Austria 100
KR - Corea 97
CI - Costa d'Avorio 83
CH - Svizzera 79
BD - Bangladesh 45
NL - Olanda 38
PL - Polonia 33
AR - Argentina 31
MX - Messico 30
IQ - Iraq 29
SA - Arabia Saudita 26
BE - Belgio 23
ID - Indonesia 21
CO - Colombia 20
ES - Italia 19
MA - Marocco 19
CR - Costa Rica 17
PK - Pakistan 16
AU - Australia 15
JM - Giamaica 15
LT - Lituania 14
SN - Senegal 14
ZA - Sudafrica 14
CZ - Repubblica Ceca 13
GR - Grecia 13
EC - Ecuador 11
MY - Malesia 11
UZ - Uzbekistan 11
GT - Guatemala 10
NG - Nigeria 10
NI - Nicaragua 10
VE - Venezuela 10
DK - Danimarca 9
IL - Israele 9
JO - Giordania 8
PH - Filippine 8
TT - Trinidad e Tobago 8
AE - Emirati Arabi Uniti 7
EE - Estonia 7
IR - Iran 7
NP - Nepal 7
PT - Portogallo 7
RO - Romania 7
AF - Afghanistan, Repubblica islamica di 6
CL - Cile 6
KE - Kenya 6
PY - Paraguay 6
TW - Taiwan 6
AL - Albania 5
EG - Egitto 5
KZ - Kazakistan 5
PA - Panama 5
SV - El Salvador 5
TN - Tunisia 5
IE - Irlanda 4
OM - Oman 4
SC - Seychelles 4
UY - Uruguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
BY - Bielorussia 3
EU - Europa 3
NO - Norvegia 3
BJ - Benin 2
DZ - Algeria 2
GP - Guadalupe 2
HR - Croazia 2
HU - Ungheria 2
KW - Kuwait 2
LB - Libano 2
MQ - Martinica 2
NZ - Nuova Zelanda 2
PE - Perù 2
PR - Porto Rico 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
AG - Antigua e Barbuda 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
Totale 20.793
Città #
Ashburn 1.334
Woodbridge 974
Singapore 828
Dallas 719
Ann Arbor 661
Hong Kong 647
San Jose 645
Chandler 583
Milan 538
Houston 517
Santa Clara 515
Fairfield 453
Shanghai 349
Sofia 281
Beijing 261
Council Bluffs 255
Jacksonville 238
New York 212
Wilmington 204
Ottawa 180
Princeton 168
Cambridge 155
Los Angeles 155
Seattle 155
Serra 147
Boardman 141
Izmir 131
Nanjing 124
Hefei 110
Lawrence 109
Tokyo 103
Lauterbourg 100
Ho Chi Minh City 93
Seoul 87
Vienna 85
Abidjan 83
Frankfurt am Main 80
Rome 79
Medford 74
Dong Ket 67
Bern 65
Florence 64
London 61
Pisa 59
Istanbul 58
Buffalo 57
Dearborn 53
Des Moines 52
São Paulo 51
Bremen 49
Chicago 48
Hanoi 48
Redwood City 48
Jüchen 45
Munich 37
Orem 34
Redondo Beach 34
Nanchang 33
Washington 33
Helsinki 32
Atlanta 30
Columbus 30
San Diego 30
Kunming 29
Montreal 29
Boulder 28
Pune 25
Brooklyn 24
Toronto 24
Phoenix 23
Abbeville 22
Brussels 22
The Dalles 22
Falls Church 21
Nuremberg 21
Chennai 20
Lancaster 20
Warsaw 20
San Francisco 19
Tianjin 19
Changsha 18
Shenyang 17
Norwalk 15
Ogden 15
Renton 15
Turku 15
Boston 14
Dakar 14
Düsseldorf 14
Livorno 14
Lucca 14
Naples 14
Philadelphia 14
Hebei 13
Jiaxing 13
San José 13
Amsterdam 12
Hangzhou 12
Stockholm 12
Turin 12
Totale 14.359
Nome #
EFFECTS OF ALTERED GRAVITY ON STEM CELL BIOLOGY AND TISSUE REGENERATION IN THE PRESENCE OF CERIUM OXIDE NANOPARTICLES 284
Exogenous 3-iodothyronamine rescues the entorhinal cortex from β-amyloid toxicity 272
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum: a feasibility study 247
Development and primary characterization of a human thyroid organoid in vitro model for thyroid metabolism investigation 240
S-nitrosothiol detection in isolated perfused rat heart 222
3-Iodothyronamine modulates sarcoplasmic reticulum calcium release 218
Effect of MEN 10755, a new disaccharide analogue of doxorubicin, on sarcoplasmic reticulum Ca(2+) handling and contractile function in rat heart 218
Exercise pulmonary hypertension in chronic thromboembolic pulmonary disease without resting pulmonary hypertension: A systematic review and meta-analysis 216
Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart 216
Effects of 3-iodothyronamine (T1AM) on signaling pathways involved in synaptic plasticity and neuroprotection. 216
Cardioprotective effect of 3-iodothyronamine in perfused rat heart subjected to ischemia and reperfusion. 215
3-Iodothyronamine as a novel endogenous chemical messenger: tissue distribution and catabolism 214
Modulation of L-type calcium channel expression by sarcoplasmic reticulum calcium release 214
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 210
Preconditioning by adenosine is associated with increased sarcoplasmic reticulum phospholamban expression 209
3-iodothyronamine as a potential anti-tumor compound 205
Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signaling pathway in diabetic cardiomyopathy 204
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messenger 204
Stimulation of cardiac trace amine receptors by 3-iodothyronamine modulates tyrosine phosphorylation and induces cardioprotection 202
Modulation of Cardiac Inotropic State by 3-Iodothyronamine: Evidence for a Novel Signalling Pathway Mediated by Trace Amine-Associated Receptors 202
3-Iodothyronamine as a Novel Endogenous Chemical Messenger: Tissue Distribution and Catabolism. 198
3-Iodothyronamine (T(1)AM) induces variation in phosphorylation pattern of tyrosine residues in rat heart 197
WEIGHT LOSS WITH PRESERVED GLUCOSE HOMEOSTASIS DURING CHRONIC TREATMENT OF OBESE MICE WITH 3-IODOTHYRONAMINE (T1AM): ROLE OF THE SIRTUIN FAMILY 197
Farmaci antineoplastici e tossicità cardiovascolare 196
Modulation of sarcoplasmic reticulum calcium channel by adenosine: a PKC-dependent pathway 195
Effects of Zofenopril on Cardiac Sarcoplasmic Reticulum Calcium Handling 195
Metabolic reprogramming by 3-Iodothyronamine (T1AM): a new perspective to reverse obesity through co-regulation of sirtuin 4 and 6 expression 194
A1 adenosine receptor stimulates phospholamban expression 193
3-iodothyronamine (T1AM) induces changes on glutamatergic postsynaptic signaling pathway 192
Vascular Progenitor Cells: From Cancer to Tissue Repair 190
Characterization of 3-Iodothyronamine In Vitro Dynamics by Mathematical Modeling 190
Cardiac effects of trace amines: Pharmacological characterization of trace amine-associated receptors 189
Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism 188
Cardioprotective effect of growth hormone secretagogues in rat heart 187
Assay of endogenous 3,5-diiodo-L-thyronine (3,5-T2) and 3,3’-diiodo-L-thyronine (3,3’-T2) in human serum. 187
A new signalling pathway mediated by 3-iodothyronamine in rat heart 186
Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors 186
A3 adenosine receptor stimulation modulates sarcoplasmic reticulum Ca2+ release in rat heart 185
Cardioprotective effect of zofenopril in perfused rat heart subjected to ischemia and reperfusion 185
Cardioprotection by ranolazine in perfused rat heart 185
Deciphering the potential of 3-iodothyronamine (T1AM) in regulating lipid metabolism 185
Artificially altered gravity elicits cell homeostasis imbalance in planarian worms, and cerium oxide nanoparticles counteract this effect 185
Effects of A1 adenosine receptor stimulation on the expression of genes involved in calcium homeostasis 185
3-Iodothyronamine Modulates Sarcoplasmic Reticulum Calcium Release 182
Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors. 182
3,5-diiodo-L-thyronine increases glucose consumption in cardiomyoblasts without affecting the contractile performance in rat heart 181
Evaluation of 3-iodothyronamine (T1AM) in cell preparation, tissue homogenates and biological fluids by HPLC-ESI-MS-MS 179
Tissue Distribution and Cardiac Metabolism of 3-Iodothyronamine 178
3-Iodothyronamine (T1AM) modifies tyrosine phosphorylation pattern in rat heart 177
Cardioprotective effect of growth hormone secretagogues in rat heart 176
3-Iodothyronamine (T1AM) induces variation in the phosphorylation pattern of thyrosine residues in rat heart 175
A1 receptor stimulation induces changes in calcium homeostasis 173
3-Iodothyronamine (T1AM) signalling pathway involves tyrosine phosphorylation in rat heart 172
Modulation of the cardiac sarcoplasmic reticulum release by adenosine: a protein kinase C-dependent pathway 171
Cardiac metabolism of 3-iodothyronamine 170
Up-take of thyronines and 3-iodothyronamine in liver cells 170
Modulation of cardiac calcium homeostasis by 3-iodothyronamine 170
3-Iodothyronamine and 3,5,3’-triiodo-L-thyronine reduce SIRT1 protein expression in HepG2 cell line. 170
Cross-talk” between L-type sarcolemmal calcium channels and sarcoplasmic reticulum calcium release channels in rat myocardium 169
Recovery of 3-iodothyronamine and derivatives in biological matrices: problems and pitfalls 169
Cardiac effects of thyronamines 168
Short-term effects of pressure overload on the expression of genes involved in calcium homeostasis 165
Cardiac effects of 3-iodothyronamine: a new aminergic system modulating cardiac function 163
Effect of 3-iodothyronamine on myocardial calcium homeostasis 162
Modulation of cardiac inotropic state by 3-iodothyronamine: evidence for a novel signalling pathway mediated by trace amine-associated receptors 159
New insights into the thyroid endocrine system by HPLC-ESI-MS-MS 158
3-Iodothyronamine cardiac metabolism: new insights resulting from liquid chromatography tandem mass spectrometry analysis 158
Effects of 3-iodothyronamine (T1AM) on long term potentiation (LTP) postsynaptic signaling cascade 158
Effects of 3-Iodothyronamine on Sarcoplasmic Reticulum Calcium Release in Rat Heart 157
Cardioprotection by 3-iodothyronamine, a new endogenous chemical messanger 156
Ghrelin tissue distribution: comparison between gene and protein expression 156
Ca2+-induced remodeling of Ca2+ channels in myocardium 155
Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat 155
Chronic carbamazepine selectively downregulates cytosolic phospholipase A2 expression and cyclooxygenase activity in rat brain 155
Ca2+ channel remodelling in perfused heart: effects of mechanical work and interventations affecting Ca2+ cycling on sarcolemmal and sarcoplasmic reticulum Ca2+ channels 155
Empagliflozin restores autophagy and attenuates ponatinib-induced cardiomyocyte senescence and death 153
Chronic carbamazepine decreases the expression and the activity of cytosolic phospholipase A2 in rat brain 153
Preconditioning by adenosine is associated with increased sarcoplasmic reticulum phopsholamban expression 153
Metabolome dynamics of T1AM, an endogenous thyroid hormone derivative: Effects on lipid metabolism, weight loss, and appetite in mice. 153
Effects of 3,5-diiodo-L-thyronine on the cardiac tissue 153
3-Iodothyronamine (T1AM), an endogenous fast acting thyroid hormone derivative: novel evidence for weight loss and glucose co-regulation by RNA gene expression 152
Effect of acute and chronic zofenopril administration on cardiac calcium homeostasis 152
3-iodothyronamine is a novel endogenous modulator of cardiac function 151
Cardioprotection and energy metabolism modulation by 3-iodothyronamine, a new endogenous chemical messanger 151
Cardiac Functional Effects of 3-Iodothyronamine, a New Endogenous Thyroid Hormone Derivative 151
Empaglifozin alleviates diabetic cariomyopathy via inhibiting excessive autophagy and adverse remodelling in type I diabetic mice. 150
Effect of ghrelin and synthetic growth hormone secretagogues in normal and ischemic rat heart 150
La biochimica di Thomas M. Devlin 149
3-Iodothyronamine cardiac metabolism: new insights resulting from liquid chromatography tandem mass spectrometry analysis 148
Biochemical basis of ischemic heart injury and of cardioprotective interventions 148
New insights into 3-iodothyronamine (T1AM) cardiac metabolism by LC/MS/MS 147
Modulation of sarcoplasmic reticulum calcium channel by adenosine: a PKC-dependent pathway 147
T1AM A MASTER REGULATOR AND A POTENTIAL DRUG OF SIRTUIN PROTEINS: APPLICATIONS TO AGING AND CANCER 147
A3 adenosine receptor stimulation modulates sarcoplasmic reticulum calcium release, 146
Modulation of calcium channel expression in rat myocardium by work load 146
Detecting 3-iodothyronamine in the presence of fetal bovine serum: isotope kinetic effect and other pitfalls 146
Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway 143
Selective downregulation of brain cytosolic phospholipase A2 activity and protein in rats treated chronically with carbamazepine 143
Cardioprotection by A3 adenosine agonists: role of sarcoplasmic reticulum calcium release 143
Uptake and metabolic effects of 3-iodothyronamine (T1AM) in hepatocytes 142
Totale 17.859
Categoria #
all - tutte 56.127
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.127


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022957 0 0 0 0 220 160 29 46 53 51 90 308
2022/20231.732 223 243 130 191 189 224 8 107 283 8 94 32
2023/20241.515 218 198 186 128 241 245 43 41 30 27 38 120
2024/20253.697 38 173 41 162 397 302 388 207 357 526 447 659
2025/20264.507 229 568 492 531 417 387 712 175 272 328 219 177
2026/20272.603 165 484 908 865 181 0 0 0 0 0 0 0
Totale 20.997